+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Computational Biology - Global Strategic Business Report

  • PDF Icon

    Report

  • 179 Pages
  • April 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5139849

Global Computational Biology Market to Reach $25.4 Billion by 2030

The global market for Computational Biology estimated at US$8 Billion in the year 2023, is projected to reach a revised size of US$25.4 Billion by 2030, growing at a CAGR of 15.6% over the analysis period 2023-2030. Contract Services, one of the segments analyzed in the report, is expected to record 16.5% CAGR and reach US$18 Billion by the end of the analysis period. Growth in the In-House Services segment is estimated at 13.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.5 Billion, While China is Forecast to Grow at 14.7% CAGR

The Computational Biology market in the U.S. is estimated at US$2.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$4.3 Billion by the year 2030 trailing a CAGR of 14.7% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.8% and 13.3% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 11.4% CAGR.

Report Features

  • Full access to influencer engagement stats
  • Access to digital archives & research platform. The proprietary platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. The state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
  • Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
  • Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
  • Complimentary report updates for one year
  • Competitor coverage with global market shares of major players
  • Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
  • Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 11 Featured) -

  • Certara LP
  • Chemical Computing Group ULC
  • Compugen Ltd.
  • Dassault Systemes
  • Genedata AG
  • Insilico Biotechnology AG
  • Leadscope, Inc.
  • Nimbus Therapeutics
  • Rosa & Co. LLC
  • Schrodinger LLC
  • Simulations Plus, Inc.
  • Strand Life Sciences Pvt., Ltd.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Computational Biology - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for In-House Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World 8-Year Perspective for In-House Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 3: World Recent Past, Current & Future Analysis for Contract Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 4: World 8-Year Perspective for Contract Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 6: World 8-Year Perspective for Academics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Commercial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World 8-Year Perspective for Commercial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 9: World Computational Biology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 10: World Recent Past, Current & Future Analysis for Computational Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 11: World 8-Year Perspective for Computational Biology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
  • Table 12: World Recent Past, Current & Future Analysis for Drug Discovery & Disease Modelling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 13: World 8-Year Perspective for Drug Discovery & Disease Modelling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Cellular & Biological Simulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 15: World 8-Year Perspective for Cellular & Biological Simulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Clinical Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 17: World 8-Year Perspective for Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 18: World Recent Past, Current & Future Analysis for Preclinical Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 19: World 8-Year Perspective for Preclinical Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Human Body Simulation Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 21: World 8-Year Perspective for Human Body Simulation Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 23: World 8-Year Perspective for Industrial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 24: USA Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 25: USA 8-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2023 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 27: USA 8-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2023 & 2030
  • Table 28: USA Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 29: USA 8-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2023 & 2030
CANADA
  • Table 30: Canada Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 31: Canada 8-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2023 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 33: Canada 8-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2023 & 2030
  • Table 34: Canada Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 35: Canada 8-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2023 & 2030
JAPAN
  • Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 36: Japan Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 37: Japan 8-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2023 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 39: Japan 8-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2023 & 2030
  • Table 40: Japan Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 41: Japan 8-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2023 & 2030
CHINA
  • Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 42: China Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 43: China 8-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2023 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 45: China 8-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2023 & 2030
  • Table 46: China Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 47: China 8-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2023 & 2030
EUROPE
  • Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 48: Europe Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 49: Europe 8-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2023 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 51: Europe 8-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2023 & 2030
  • Table 52: Europe Recent Past, Current & Future Analysis for Computational Biology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 53: Europe 8-Year Perspective for Computational Biology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
  • Table 54: Europe Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 55: Europe 8-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2023 & 2030
FRANCE
  • Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 57: France 8-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2023 & 2030
  • Table 58: France Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 59: France 8-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2023 & 2030
  • Table 60: France Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 61: France 8-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2023 & 2030
GERMANY
  • Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 63: Germany 8-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2023 & 2030
  • Table 64: Germany Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 65: Germany 8-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2023 & 2030
  • Table 66: Germany Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 67: Germany 8-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2023 & 2030
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 69: Italy 8-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2023 & 2030
  • Table 70: Italy Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 71: Italy 8-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2023 & 2030
  • Table 72: Italy Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 73: Italy 8-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2023 & 2030
UNITED KINGDOM
  • Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 75: UK 8-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2023 & 2030
  • Table 76: UK Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 77: UK 8-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2023 & 2030
  • Table 78: UK Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 79: UK 8-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2023 & 2030
REST OF EUROPE
  • Table 80: Rest of Europe Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 81: Rest of Europe 8-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2023 & 2030
  • Table 82: Rest of Europe Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 83: Rest of Europe 8-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2023 & 2030
  • Table 84: Rest of Europe Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 85: Rest of Europe 8-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2023 & 2030
ASIA-PACIFIC
  • Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 87: Asia-Pacific 8-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2023 & 2030
  • Table 88: Asia-Pacific Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 89: Asia-Pacific 8-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2023 & 2030
  • Table 90: Asia-Pacific Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 91: Asia-Pacific 8-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2023 & 2030
REST OF WORLD
  • Table 92: Rest of World Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 93: Rest of World 8-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2023 & 2030
  • Table 94: Rest of World Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 95: Rest of World 8-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2023 & 2030
  • Table 96: Rest of World Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 97: Rest of World 8-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2023 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Certara LP
  • Chemical Computing Group ULC
  • Compugen Ltd.
  • Dassault Systemes
  • Genedata AG
  • Insilico Biotechnology AG
  • Leadscope, Inc.
  • Nimbus Therapeutics
  • Rosa & Co. LLC
  • Schrodinger LLC
  • Simulations Plus, Inc.
  • Strand Life Sciences Pvt., Ltd.

Table Information